Main Session
Sep
29
QP 30 - HPV-associated oropharyngeal cancer (HPVOPC): De-escalation, Volumes, and Outcomes
1176 - Practice Variation In IMPT Treatment Planning in Oropharyngeal Cancer: Dose Differences and Expected Impact on Toxicity Outcome
Presenter(s)
Johannes Langendijk, MD, PhD - University Medical Center Groningen, Groningen, Groningen